Hansoh Pharmaceutical (3692) Nukunuku Sɛn
Prévision IA: 3692
AI ɖo nɔvɔxɔsisa ɖo xɔsin ɖo gbe ɖagbe, xɔsin ɖo xwe ɖagbe, kpodo xɔsin ɖo xwe ɖagbe kpo. Xɔsin ɖo xɔsin ɖo xɔsin ɖo xɔsin. Xɔsin ɖo xɔsin ɖo xɔsin, ɖo xɔsin ɖo xɔsin.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA pour 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Déverrouiller Premium🔒 Nukunukunukunukunuku
The forecast track record — every past forecast next to the actual close — is part of Premium.
Déverrouiller PremiumGɔn Kɛntɔn E Nɔví
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).
